Short communicationSelective placental transport of maternal IgG to the fetus
References (18)
- et al.
Two-site immunoenzymometric assay for serum IgG subclass infant/maternal ratios at full term
Journal of Immunological Methods
(1988) - et al.
Interaction of aglycosyl IgG with the IgG Fc transport receptor from neonatal rat gut: comparison of deglycosylation by tunicamycin treatment and genetic engineering
Molecular Immunology
(1992) - et al.
Galactosylation of IgG associated oligosaccharides: reduction in patients with adult and juvenile onset rheumatoid arthritis in relation to disease
Lancet
(1988) - et al.
A comparative analysis of disease-associated changes in the galactosylation of serum IgG
Journal of Autoimmunity
(1989) - et al.
Changes in IgG glycoform levels are associated with remission of arthritis during pregnancy
Journal of Autoimmunity
(1991) - et al.
Serum IgG levels in normal, premature, post-mature and small for dates newborn babies
Lancet
(1968) - et al.
The β1-2-d-xylose and α1-3-l-fucose substituted N-linked oligosaccharides from Erythrina cristagalli lectin
European Journal of Biochemistry
(1987) - et al.
Crystal structure at 2.2A resolution of the MHC-related neonatal Fc receptor
Nature
(1994) - et al.
Crystal structure of the complex of rat neonatal Fc receptor with Fc
Nature
(1994)
Cited by (43)
Contribution of the ex vivo placental perfusion model in understanding transplacental immunoglobulin G transfer
2022, PlacentaCitation Excerpt :It has been instrumental for our understanding that FcγRs do not contribute the transfer of IgG across human placenta to the same degree as FcRn [24,57–61]. Rather, such receptors may modulate the transfer [59,65–67]. The current understanding of the process of antibody transplacental transport has so far resulted in clinical trials to treat alloimmune mediated pregnancy complications with nipocalimab, which is promising for the treatment of hemolytic diseases.
Human IgG Glycosylation in Inflammation and Inflammatory Disease
2021, Comprehensive Glycoscience: Second EditionMaternal immunisation: collaborating with mother nature
2017, The Lancet Infectious DiseasesCitation Excerpt :Two studies79,80 have suggested that high avidity antibodies can be transferred preferentially across the placenta. Previously, studies also suggested a preferential transfer of hypergalactosylated IgG, but this theory was not supported by a more recent study that used more advanced technologies, which showed that Fc galactosylation had no effect on IgG transfer.81,82 Chronic maternal infections and hypergammaglobulinaemia have a profound effect on maternal antibody transfer.69
Passively Acquired Antibody-Dependent Cellular Cytotoxicity (ADCC) activity in HIV-infected infants is associated with reduced mortality
2015, Cell Host and MicrobeCitation Excerpt :A more intriguing possibility is that the differences between maternal and infant ADCC are due to differences in passive transfer of antibodies to the infants. IgG subclass and the glycosylation profile of antibodies impact ADCC activity and have also been suggested to be differentially transferred across the placenta (Ackerman et al., 2013; Ferrante et al., 1990; Hashira et al., 2000; Simister, 2003; Williams et al., 1995; Wren et al., 2013), suggesting that maternal ADCC antibody levels may not always be indicative of infant repertoires. In any case, these results have important implications given that prior studies often focused on the relationship between maternal antibody responses, rather than infant responses, and protection.
N-glycomic biomarkers of biological aging and longevity: A link with inflammaging
2013, Ageing Research ReviewsCitation Excerpt :Moreover, the level of galactosylation was much lower among ACPA than in IgG repertoire (Ercan et al., 2010). Galactosylation could influence the placental transport of antibodies, in that the level of IgG-G0 is always lower in the fetus than in its mother (Williams et al., 1995; Kibe et al., 1996). Nevertheless, IgG-G0 antibodies appear to be involved in the transmission from mother to child of autoimmune diseases, such as systemic lupus erythematosus (SLE) (Pilkington et al., 1996b) and myastenia gravis (Pilkington et al., 1995a).